GLP-1 Weight Loss Results: How Much Can You Lose?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed how doctors approach weight management, with clinical trials showing average weight loss of 10–22% of starting body weight depending on the medication and dosage. Your actual results depend on your metabolism, genetics, diet choices, and how consistently you use the medication. Understanding what realistic weight loss looks like helps you set achievable goals and track your progress.

Average Weight Loss With GLP-1 Medications

Semaglutide, one of the most studied GLP-1 medications, helped patients in clinical trials lose an average of 15% of their starting weight over 68 weeks of treatment. In the STEP trials, participants taking semaglutide lost significantly more weight than those on placebo, with weight loss continuing for the full duration of treatment. The medication works by reducing hunger signals in your brain and slowing how fast your stomach empties, making you feel fuller longer.

Individual results vary widely—some patients lose 5–10% of their weight while others achieve 20% or more. Factors like your starting weight, age, metabolism, physical activity level, and diet quality all influence your personal weight loss trajectory. PlexusDx works with licensed 503A compounding pharmacies to provide semaglutide injections that start at $149/month, making this proven therapy accessible without insurance requirements.

Timeline: When You'll Notice Weight Loss Changes

Most patients begin noticing appetite suppression within the first 1–2 weeks of starting GLP-1 therapy, though visible weight loss typically appears around weeks 3–6. The first month often brings 1–3 pounds of weight loss as your body adjusts to reduced calorie intake from decreased hunger. Momentum builds over the following months, with average weight loss of 1–2 pounds per week becoming common by month two and beyond.

By month three, many patients see measurable changes in how their clothes fit and energy levels improve. The pace of weight loss typically plateaus around months 4–6, then continues at a slower but steady rate through months 6–12. This natural progression means patience is essential—rapid initial losses often slow, which is normal and healthy biology, not a sign of treatment failure.

Comparing Semaglutide, Tirzepatide, and Dual-Compound Options

Semaglutide targets GLP-1 receptors alone and produced average weight loss of 15% in landmark trials, making it highly effective for most patients. Tirzepatide activates both GLP-1 and GIP receptors, delivering average weight loss of 20–22% in clinical studies—roughly 5–7 percentage points greater than semaglutide. PlexusDx offers both medications as compounded injections, with tirzepatide starting at $249/month, giving you options based on your goals and medical history.

For patients seeking maximum effect, PlexusDx's GLP-Squared Injection combines semaglutide and tirzepatide in one dose, starting at $249/month. This dual-compound approach may appeal to those who didn't achieve desired results with a single medication or prefer optimized therapy from the start. Your healthcare provider at PlexusDx can help determine which option aligns with your weight loss targets and medical background.

Genetic Factors That Influence Your Weight Loss Potential

Your genes play a significant role in how your body responds to GLP-1 therapy—some people naturally have greater appetite sensitivity or metabolic flexibility that enhances results. PlexusDx's Precision Peptide Genetic Test ($99 after your first month of treatment) analyzes key genetic variants including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 that predict how your peptide pathways respond to therapy. Understanding your genetic profile helps personalize your treatment plan and set realistic expectations based on your unique biology.

The FTO gene variant, for example, influences how your body regulates hunger hormones and energy storage. Patients with certain genetic patterns may experience faster appetite suppression or more consistent weight loss with GLP-1 medications. PlexusDx maps 14 metabolic pathways across 49 peptides using over 150 genetic insights, allowing your provider to optimize your medication choice and dosing strategy for maximum personal benefit.

How to Maximize Your Weight Loss Results

Medication is a tool, not a substitute for healthy habits—combining GLP-1 therapy with consistent exercise, whole-food nutrition, and adequate sleep produces the best outcomes. Patients who lose the most weight typically walk 150+ minutes per week, prioritize protein intake, and drink sufficient water to support metabolism and reduce false hunger signals. GLP-1 medications make these healthy choices easier by reducing cravings and food noise, but your daily decisions still matter enormously.

Track your progress beyond the scale by monitoring energy levels, clothes fit, blood sugar stability, and how you feel during physical activity. Weight loss isn't always linear—many patients experience 2–3 week plateaus followed by sudden drops, which is completely normal. PlexusDx supports your journey with licensed 503A compounded medications starting at $149/month for semaglutide, HSA/FSA eligibility, and access to healthcare guidance—no membership fees or insurance requirements needed.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I personally lose with GLP-1?

Average weight loss ranges from 10–22% of starting body weight depending on the specific medication, your genetics, lifestyle, and how long you use it. PlexusDx's Precision Peptide Genetic Test can reveal your individual genetic predispositions for GLP-1 response, helping your provider set more accurate expectations for your situation.

What clinical evidence supports GLP-1 weight loss claims?

The STEP clinical trials demonstrated that semaglutide produced average weight loss of 15% over 68 weeks, while tirzepatide achieved 20–22% in similar studies. These results represent sustained weight loss in real patients taking the medication as prescribed, not temporary or short-term changes.

Is PlexusDx semaglutide FDA-approved?

PlexusDx semaglutide is compounded by licensed 503A pharmacies using FDA-approved reference formulations and rigorous quality standards. While PlexusDx does not manufacture FDA-approved products, the active ingredient and compounding process meet strict regulatory requirements for safety and efficacy.

Will I regain weight if I stop taking GLP-1?

Some weight regain is common after stopping GLP-1 therapy because appetite hormones return to baseline, but research shows most patients maintain 50–70% of their weight loss long-term if they sustain healthy habits. Many patients choose to stay on maintenance doses of GLP-1 to preserve results—PlexusDx pricing ($149/month for semaglutide) suppor...

How can genetic testing help me achieve better results?

The Precision Peptide Genetic Test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R genes that predict how strongly you'll respond to GLP-1 therapy and which peptide pathways drive your weight regulation. This allows your PlexusDx provider to choose semaglutide, tirzepatide, or dual-compound therapy and set realistic timelines base...

How Much Weight Can You Lose on GLP-1 Medications?